Cleared Special

K103173 - VITOSS BA BIMODAL BIOACTIVE BONE GRAFT SUBSTITUTE

K103173 is an FDA 510(k) clearance for VITOSS BA BIMODAL BIOACTIVE BONE GRAFT ..., manufactured by Orthovita, Inc.. The device is a Class 2 Orthopedic device with product code MQV cleared through the Special 510(k) pathway after a 102-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Feb 2011
Decision
102d
Days
Class 2
Risk

K103173 is an FDA 510(k) clearance for the VITOSS BA BIMODAL BIOACTIVE BONE GRAFT SUBSTITUTE. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Orthovita, Inc. (Malver, US). The FDA issued a Cleared decision on February 7, 2011 after a review of 102 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K103173

510(k) Number K103173 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 28, 2010
Decision Date February 07, 2011
Days to Decision 102 days
Submission Type Special
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 122d · This submission: 102d
Pathway characteristics
Modification to existing cleared device.

MQV Device Classification - Class 2, Special Controls

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 492
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K103173.
NOVABONE PUTTY - BIOACTIVE SYNTHETIC BONE GRAFT
K110368 · Novabone Products, LLC · Apr 2011
DBX DEMINERALIZED BONE MATRIX PUTTY
K103784 · Musculoskeletal Transplant Foundation · Apr 2011
DBX DEMINERALIZED BONE MATRIX PUTTY
K103795 · Musculoskeletal Transplant Foundation · Apr 2011
NORIAN DRILLABLE INJECT, NORIAN DRILLABLE FAST SET PUTTY
K102722 · Synthes USA Products, LLC · Jan 2011
ALLOFUSE PLUS
K103036 · Allosource, Inc. · Jan 2011
OSTEOPHIL BETA-TCP
K102937 · Cytophil, Inc. · Dec 2010